nVerses Capital’s Transmedics TMDX Stock Holding History

nVerses Capital’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,644	Closed	-$362K	–	531
2026 Q1	$362K	Buy	+3,644	New	+$475K	0.33%	120
2024 Q4	–	Sell	-2,200	Closed	-$345K	–	816
2024 Q3	$345K	Buy	2,200 +600	+38%	+$92.5K	0.16%	207
2024 Q2	$241K	Buy	+1,600	New	+$192K	0.14%	229

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

nVerses Capital's TMDX Position: Q2 2026 in Review

nVerses Capital sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 3,644 shares — an estimated $362K sold.

nVerses Capital first reported a position in TMDX in Q2 2024 and held it in 3 quarters. The position peaked at $362K in Q1 2026. 285 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

nVerses Capital reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 3,644 Transmedics shares in Q2 2026, an estimated $362K.
nVerses Capital first reported a position in Transmedics in Q2 2024 and held it in 3 quarters.
nVerses Capital's Transmedics position peaked at $362K in Q1 2026.
285 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.